Plainsboro, NJ, United States of America

Zhaoning Zhu

This inventor holds 71 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 22 EPO patents, primarily in Aspartyl Protease Inhibitors (CPC class C07D). Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Ucb Biopharma Sprl. Active years: 2002-2022.

USPTO Granted Patents = 71 (Patent Applications = 12)

% Patents Active = 77.5

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 22 (Patent Applications = 23)

Average Co-Inventor Count = 7.4

ph-index = 9

Forward Citations = 468(Granted Patents)

Forward Citations (Not Self Cited) = 398(Dec 10, 2025)

Inventors with similar research interests:

Location History:

East Windsor, NJ (US) (2002 - 2012)
Warfield, GB (2015)
Plainsboro, NJ (US) (2005 - 2016)
Warfield Berkshire, GB (2017)
Slough, GB (2016 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

9. 3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Aspartyl Protease Inhibitors

Gamma Secretase Modulators

TNF Modulators

Imidazole Derivatives

Hexahydropyrimidine Analogues

Fused Pentacyclic Compounds

Iminothiadiazinane Dioxide Derivatives

Spirocyclic Indolines

Substituted Isoindolines

Fused Tricyclic Benzimidazoles

Fused Tricyclic Imidazole Derivatives

Fused Bicyclic Heteroaromatic Derivatives

71 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11479546 - Antimalarial hexahydropyrimidine analogues (2022-10-25),

2. 11472794 - Fused imidazole derivatives as IL-17 modulators (2022-10-18),

3. 11136310 - Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors (2021-10-05),

4. 11052076 - Spirocyclic indolines as IL-17 modulators (2021-07-06),

5. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity (2021-04-20),

6. 10953019 - Fused pentacyclic imidazole derivatives as modulators of TNF activity (2021-03-23),

7. 10906919 - Fused pentacyclic imidazole derivatives (2021-02-02),

8. 10464932 - Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors (2019-11-05),

9. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity (2019-05-14),

10. 10202405 - Fused pentacyclic imidazole derivatives (2019-02-12),

11. 10087179 - Fused tricyclic imidazole derivatives as modulators of TNF activity (2018-10-02),

12. 10004737 - Fused imidazole and pyrazole derivatives as modulators of TNF activity (2018-06-26),

13. 9932343 - Fused tricyclic benzimidazoles derivatives as modulators of TNF activity (2018-04-03),

14. 9890174 - Fused Tricyclic imidazole derivatives as modulators of TNF activity (2018-02-13),

15. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity (2017-11-14),

Title: The Innovative Journey of Zhaoning Zhu

Introduction: Zhaoning Zhu, a talented inventor based in Plainsboro, NJ (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Zhaoning Zhu holds several patents in various technological domains, showcasing his versatility and creativity in innovation.

Career Highlights: Throughout his illustrious career, Zhaoning Zhu has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His passion for technology and commitment to excellence have led to the successful commercialization of several of his inventions.

Collaborations: Zhaoning Zhu has collaborated with leading research institutions, universities, and companies to further his research and bring his inventions to life. His collaborative spirit and dedication to teamwork have been instrumental in the success of his projects.

Conclusion: Zhaoning Zhu's innovative spirit, coupled with his dedication to pushing the boundaries of technology, has established him as a prominent figure in the world of inventions. His contributions continue to inspire future generations of inventors to think outside the box and pursue their creative ideas relentlessly.